(Q91207859)

English

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

scientific article published on 26 August 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

George A. Howard

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Michał Tendera

11

object named as

Michal Tendera

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

object named as

Carlos Brotons

2

0 references

author name string

J Michael Gaziano

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Rosa Coppolecchia

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Claudio Cricelli

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Harald Darius

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Philip B Gorelick

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Thomas A Pearson

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Peter M Rothwell

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Luis Miguel Ruilope

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Gianni Tognoni

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

ARRIVE Executive Committee

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

publication date

26 August 2018

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

392

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

10152

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1036-1046

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30158069%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Updated Meta-Analysis of Aspirin in Primary Prevention of Cardiovascular Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931924-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q91207859&oldid=1971098976"